XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Operating Activities    
Net loss $ (58,289) $ (13,621)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation, amortization and accretion 9,201 5,714
Impairment of intangible assets 12,825 195
Stock-based compensation expense 3,574 1,079
Loss (gain) from contingent considerations (4,459) (10,430)
Inventory write-down 7,332 1,265
Changes in allowance for bad debt 608 405
Loss on debt extinguishment 1,569 316
Amortization of senior debt discount (premium) (44) 532
Other noncash adjustments 38 46
Changes in operating assets and liabilities:    
Accounts receivable 1,544 (3,561)
Inventory 2,786 (8,216)
Prepaid expenses and other current assets 157 (6,066)
Accounts payable and other (3,245) (1,377)
Accrued liabilities 771 5,345
Other operating assets and liabilities, net (332) 0
Net cash used in operating activities (25,964) (28,374)
Investing Activities    
Contingent consideration payment (683) (203)
Cash received from acquisition 15,722 391
Cash payment for business acquisition (15,520) (5,850)
Cash payment for asset acquisition (2,341) 0
Other investing activities 40 6
Net cash used in investing activities (2,782) (5,656)
Financing Activities    
Proceeds from issuance of stock 45,051 65,730
Payment of stock issuance costs (4,903) (5,404)
Warrant exercises 0 26,992
Payment made to fix payment arrangement (6,088) 0
Payments made to borrowings (54,947) (19,437)
Proceeds from borrowings 51,206 3,188
Other financing activities (5) 0
Net cash provided by financing activities 30,314 71,069
Net change in cash, restricted cash and cash equivalents 1,568 37,039
Cash, cash equivalents and restricted cash at beginning of period 48,333 11,294
Cash, cash equivalents and restricted cash at end of period 49,901 48,333
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets    
Cash and cash equivalents 49,649 48,082
Restricted cash 252 251
Total cash, cash equivalents and restricted cash 49,901 48,333
Supplemental cash flow data    
Cash paid for interest 1,249 1,040
Non-cash investing and financing activities:    
Contingent value rights payout 1,000 2,000
Issuance of common stock for note conversion 1,058 2,579
Estimated fair value of replacement equity awards 432 0
Fair value of liabilities assumed 88,700 0
Fair value of non-cash assets acquired 104,322 0
Issuance cost related to S-3 0 1,531
Issuance of stock for business acquisition 53,104 18,365
Other noncash investing and financing activities 0 1,607
Warrants issued $ 1,628 $ 0